In NASH-HCC models, lack of FGF21 caused significant upregulation of the hepatocyte-derived IL-17A via TLR4 and NF-κB signaling, which suggests that FGF21 and NF-κB may be involved in the transition of NASH-HCC. Here, NFKB1 is linked to hepatocellular carcinoma.